homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

February 25, 2004

Icogen

Icogen Corp., a Seattle-based biotechnology company, is changing its name to Icogenex Corp.

The name change reflects a refocusing and re-branding of the company. "We are now a different company from the one founded in 1995," said Frederick S. Hagen, president and CEO. Icogen is developing anti-inflammatory therapeutics and therapy for Alzheimer's disease.




Email or user name:
Password:
 
Forgot password? Click here.